BRAF and MEK inhibitor-associated optic neuropathy in stage IIIC BRAF+ melanoma. Carrabba NV, Siliezar PD, Laylani N, Lee AG, et al. Can J Ophthalmol 2023 Aug 3:S0008-4182(23)00233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carrabba NV, Siliezar PD, Laylani N, Lee AG, et al. BRAF and MEK inhibitor-associated optic neuropathy in stage IIIC BRAF+ melanoma. Can J Ophthalmol 2023 Aug 3:S0008-4182(23)00233.
PMID: 37545048